Siegfried Holding AG (LON:0QQO)

Market Cap	3.26B
Revenue (ttm)	1.19B
Net Income (ttm)	141.43M
Shares Out	n/a
EPS (ttm)	3.23
PE Ratio	23.04
Forward PE	19.95
Dividend	0.35 (0.43%)
Ex-Dividend Date	Apr 22, 2025

Volume	10,018
Average Volume	13,602
Open	83.20
Previous Close	82.67
Day's Range	81.60 - 83.20
52-Week Range	59.10 - 117.40
Beta	0.71
RSI	38.14
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1873
• Employees: 3,886
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QQO

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.

Financial numbers in CHF